DaVita Inc.
$196.88+1.17%(+$2.27)
TickerSpark Score
69/100
95
Valuation
55
Profitability
35
Growth
60
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DVA research report →
52-Week Range94% of range
Low $101.00
Current $196.88
High $202.69
Companywww.davita.com
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
- CEO
- Javier J. Rodriguez
- IPO
- 1995
- Employees
- 76,000
- HQ
- Denver, CO, US
Price Chart
+35.07% · this period
Valuation
- Market Cap
- $12.64B
- P/E
- 16.98
- P/S
- 0.91
- P/B
- -17.56
- EV/EBITDA
- 9.31
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 31.10%
- Op Margin
- 15.01%
- Net Margin
- 5.65%
- ROE
- -133.12%
- ROIC
- 10.70%
Growth & Income
- Revenue
- $13.64B · 6.46%
- Net Income
- $746.80M · -20.24%
- EPS
- $9.72 · -11.80%
- Op Income
- $2.01B
- FCF YoY
- -10.63%
Performance & Tape
- 52W High
- $202.69
- 52W Low
- $101.00
- 50D MA
- $160.44
- 200D MA
- $135.68
- Beta
- 0.84
- Avg Volume
- 867.60K
Get TickerSpark's AI analysis on DVA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Pullin Dennis W | other | 250 |
| May 15, 26 | Moore Gregory J. | other | 250 |
| May 15, 26 | Schoppert Wendy Lee | other | 250 |
| May 15, 26 | Arway Pamela M | other | 250 |
| May 15, 26 | YALE PHYLLIS R | other | 250 |
| May 15, 26 | DESOER BARBARA J | other | 250 |
| May 15, 26 | Schechter Adam H | other | 250 |
| May 15, 26 | Hollar Jason M. | other | 250 |
| May 14, 26 | HEARTY JAMES O | other | 5,784 |
| May 14, 26 | HEARTY JAMES O | sell | 3,231 |
Our DVA Coverage
We haven't published any research on DVA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DVA Report →Similar Companies
ENSG+1.35%
The Ensign Group, Inc.
$178.26
ALGN+5.32%
Align Technology, Inc.
$163.42
UHS-1.27%
Universal Health Services, Inc.
$164.34
ATR+1.44%
AptarGroup, Inc.
$115.25
BIO+2.41%
Bio-Rad Laboratories, Inc.
$287.82
CHE+0.15%
Chemed Corporation
$440.71
MOH-1.16%
Molina Healthcare, Inc.
$182.24
RVMD+1.95%
Revolution Medicines, Inc.
$150.17